BKYI

BIO-key International
BKYI

$1.62

0%

Market Cap: 2.94M

About: BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

Employees: 52

Information Technology Prepackaged Software

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 7 [Q4 2023] → 7 (+0) [Q1 2024]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

6.92% less ownership

Funds ownership: 7.29% [Q4 2023] → 0.37% (-6.92%) [Q1 2024]

94% less capital invested

Capital invested by funds: $219K [Q4 2023] → $14.2K (-$204K) [Q1 2024]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for BKYI.

See Analyst Rankings

Financial journalist opinion

Williamsburg, VA Advances Zero Trust Initiative for City Infrastructure and Data with BIO-key Identity-Bound Biometrics

Williamsburg, Virginia Advances Zero Trust Initiative (Cyber Security) for City's Software Infrastructure and Data with BIO-key's Identity-Bound Biometrics

Williamsburg, VA Advances Zero Trust Initiative for City Infrastructure and Data with BIO-key Identity-Bound Biometrics

BIO-key International, Inc. (BKYI) Q1 2024 Earnings Call Transcript

BIO-key International, Inc. (NASDAQ:BKYI ) Q1 2024 Earnings Conference Call June 18, 2024 10:00 AM ET Corporate Participants Bill Jones - Investor Relations Mike DePasquale - Chairman and Chief Executive Officer Ceci Welch - Chief Financial Officer Jim Sullivan - Chief Legal Officer Conference Call Participants Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's First Quarter 2024 Conference Call.

BIO-key International, Inc. (BKYI) Q1 2024 Earnings Call Transcript

Identity, Access Management and Cybersecurity Solutions Provider BIO-key International Hosts Q1 Investor Call Tues., June 18th at 10am ET

HOLMDEL, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q1 2024 investor call Tuesday, June 18th at 10 a.m.

Identity, Access Management and Cybersecurity Solutions Provider BIO-key International Hosts Q1 Investor Call Tues., June 18th at 10am ET

Identity and Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9:00am ET

Identity, Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9am ET

Identity and Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9:00am ET

BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq

WALL, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on May 22, 2024, it received a letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“SEC”), due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Form 10-Q”). The Notification Letter has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market.

BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq

BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week

HOLMDEL, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, today announced that it currently expects to file its audited 2023 results with the SEC on Form 10-K next week.

BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week

BIO-key Wins Coveted Global InfoSec Award for Multi-factor Authentication During RSA Conference 2024

HOLMDEL, N.J. and SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less FIDO and Passkey authentication solutions through its unique Identity Bound Biometrics (IBB) capabilities, is proud to announce it has won the Hot Company Multi-Factor Authentication award from Cyber Defense Magazine (CDM), the industry's leading electronic information security magazine.

BIO-key Wins Coveted Global InfoSec Award for Multi-factor Authentication During RSA Conference 2024

BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq

HOLMDEL, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on April 17, 2024, it received a letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“SEC”).

BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq

Switzerland's Canton of Ticino Implements BIO-key's Multi-Factor Authentication Solution in its Information Systems Center

Switzerland's Canton of Ticino has partnered with Asecus AG to Implement BIO-key's Multi-Factor Authentication Solution in its Information Systems Center

Switzerland's Canton of Ticino Implements BIO-key's Multi-Factor Authentication Solution in its Information Systems Center

BIO-key International, Inc. (BKYI) Q4 2023 Earnings Call Transcript

BIO-key International, Inc. (NASDAQ:BKYI ) Q4 2023 Earnings Conference Call April 2, 2024 10:00 AM ET Company Participants Bill Jones - IR Mike DePasquale - Chairman and CEO Ceci Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's Fourth Quarter 2023 Conference Call.

BIO-key International, Inc. (BKYI) Q4 2023 Earnings Call Transcript

See News Rankings